Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 23, 2013, Pages 7269-7279

  Lee, Dayong ^a   Vandrey, Ryan ^b   Milman, Garry ^a   Bergamaschi, Mateus ^a   Mendu, Damodara R ^a   Murray, Jeannie A ^b   Barnes, Allan J ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis; Delta9 tetrahydrocannabinol; Marijuana; Oral fluid; Plasma; Ratio

Indexed keywords

CANNABIS; DELTA9-TETRAHYDROCANNABINOL; MARIJUANA; ORAL FLUIDS; RATIO;

RNA;

PLASMAS;

CANNABIS; CANNABIS SATIVA; NEPTUNIA;

CANNABINOID; DRONABINOL; PSYCHEDELIC AGENT;

ADULT; ARTICLE; BLOOD; CALIBRATION; CANNABIS SMOKING; CHEMISTRY; HUMAN; LIMIT OF DETECTION; MASS FRAGMENTOGRAPHY; SALIVA;

ADULT; CALIBRATION; CANNABINOIDS; DRONABINOL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALLUCINOGENS; HUMANS; LIMIT OF DETECTION; MARIJUANA SMOKING; SALIVA;

EID: 84883558727     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7159-8     Document Type: Article

References (38)

1. United Nations Office on Drugs and Crime (2012) World Drug Report 2012. United Nations Publication, Sales No. E.12.XI.1. Vienna, Austria
2. Substance Abuse and Mental Health Services Administration (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD
3. European Monitoring Centre for Drugs and Drug Addiction (2012) Annual Report 2012: The State of the Drugs Problem in Europe. Publications Office of the European Union. Luxembourg
4. Australian Institute of Health and Welfare (2011) 2010 National Drug Strategy Household Survey report. Drug statistics series no. 25. Cat. No. PHE 145. Canberra
5. Huestis MA (2002) Cannabis (marijuana) - effects on human behavior and performance. the effects of drugs on human performance and behavior. Central Police University Press, Taipei
6. Wadsworth EJ, Moss SC, Simpson SA, Smith AP (2006) Cannabis use, cognitive performance and mood in a sample of workers. J Psychopharmacol 20:14-23
7. Macdonald S, Hall W, Roman P, Stockwell T, Coghlan M, Nesvaag S (2010) Testing for cannabis in the work-place: a review of the evidence. Addiction 105:408-416
8. Li G, Baker SP, Zhao Q, Brady JE, Lang BH, Rebok GW, DiMaggio C (2011) Drug violations and aviation accidents: findings from the US mandatory drug testing programs. Addiction 106:1287-1292
9. Li MC, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G (2012) Marijuana use and motor vehicle crashes. Epidemiol Rev 34:65-72
10. Hartman RL, Huestis MA (2012) Cannabis Effects on Driving Skills. Clin Chem 59:478-492
11. Substance Abuse and Mental Health Services Administration (2012) Treatment Episode Data Set (TED) 2000-2010; National Admissions to Substance Abuse Treatment Services. DASIS Series S-61, HHS Publication No. (SMA) 12-4701. Rockville, MD
12. Degenhardt L, Hall W (2012) Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 379:55-70
13. Bosker WM, Huestis MA (2009) Oral fluid testing for drugs of abuse. Clin Chem 55:1910-1931
14. 9-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol 36:405-412
15. Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert G (2006) Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 85:114-122
16. Aps JK, Martens LC (2005) Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int 150:119-131
17. Gallardo E, Barroso M, Queiroz JA (2009) Current technologies and considerations for drug bioanalysis in oral fluid. Bioanalysis 1:637-667
18. Wille SM, Raes E, Lillsunde P, Gunnar T, Laloup M, Samyn N, Christophersen AS, Moeller MR, Hammer KP, Verstraete AG (2009) Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit 31:511-519
19. Drummer OH (2005) Review: pharmacokinetics of illicit drugs in oral fluid. Forensic Sci Int 150:133-142
20. Samyn N, van Haeren C (2000) On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int J Legal Med 113:150-154
21. Kauert GF, Ramaekers JG, Schneider E, Moeller MR, Toennes SW (2007) Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol 31:288-293
22. Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA (2011) Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral delta9-tetrahydrocannabinol administration. Clin Chem 57:1597-1606
23. Schwilke EW, Schwope DM, Karschner EL, Lowe RH, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA (2009) Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin Chem 55:2180-2189
24. Day D, Kuntz DJ, Feldman M, Presley L (2006) Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol 30:645-650
25. Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D (2012) The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend 128:64-70
26. Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA (2012) Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem 58:748-756
27. Schwope DM, Karschner EL, Gorelick DA, Huestis MA (2011) Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem 57:1406-1414
28. Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA (2013) Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend 130:68-76
29. Karschner EL, Darwin WD, Goodwin RS, Wright S, Huestis MA (2011) Plasma cannabinoid pharmacokinetics following controlled oral delta9- tetrahydrocannabinol and oromucosal cannabis extract administration. Clin Chem 57:66-75
30. Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA (2007) Simultaneous quantification of delta9-tetrahydrocannabinol, 11-hydroxy-delta9- tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 1163:318-327
31. Milman G, Barnes AJ, Lowe RH, Huestis MA (2010) Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 1217:1513-1521
32. Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA (2013) Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend 130:68-76
33. Kelly P, Jones RT (1992) Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J Anal Toxicol 16:228-235
34. Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF (2010) Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J Anal Toxicol 34:216-221
35. Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA (2011) Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin Chem 57:1127-1136
36. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA (2010) Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clin Chem 56:1261-1269
37. Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16:276-282
38. Ramaekers JG, Berghaus G, van Laar M, Drummer OH (2004) Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 73:109-119